Please login to the form below

Not currently logged in
Email:
Password:

myelodysplastic syndromes

This page shows the latest myelodysplastic syndromes news and features for those working in and with pharma, biotech and healthcare.

Celgene’s ‘oral Vidaza’ clears phase 3 leukaemia trial

Celgene’s ‘oral Vidaza’ clears phase 3 leukaemia trial

At its height, Vidaza was bringing in upwards of $600m a year as a treatment for AML and myelodysplastic syndromes (MDS), but has been almost entirely supplanted by generics in the

Latest news

More from news
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Pharma deals in April 2015 Pharma deals in April 2015

    Under the terms of the deal, Celgene has the rights to develop the product for non-Hodgkin lymphoma (NHL), myelodysplastic syndromes and multiple myeloma.

  • Pharma deals during September 2013 Pharma deals during September 2013

    Astex' lead product is Dacogen (decitabine) for myelodysplastic syndromes (MDS). It was also recently approved for acute myeloid leukaemia (AML) in patients over 65 years of age in Europe.

  • Pharma deals during September 2012 Pharma deals during September 2012

    Estybon is in phase III for the treatment of myelodysplastic syndromes (MDS) (rare haematologic malignancies) and in phase II/III for pancreatic cancer. ... 638. Onconova Therapeutics / Baxter International. Licence (2). Estybon (rigosertif) for

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics